Berotec N pressurised inhalation, solution

Country: Armenja

Lingwa: Ingliż

Sors: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Ingredjent attiv:

fenoterol (fenoterol hydrobromide)

Disponibbli minn:

Boehringer Ingelheim Pharma GmbH & Co. KG

Kodiċi ATC:

R03AC04

INN (Isem Internazzjonali):

fenoterol (fenoterol hydrobromide)

Dożaġġ:

100mcg/dose

Għamla farmaċewtika:

pressurised inhalation, solution

Unitajiet fil-pakkett:

10ml aluminium bottle and metering valve

Tip ta 'preskrizzjoni:

Prescription

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2018-05-07

Karatteristiċi tal-prodott

3,
PHARMACEUTICAI
FORM
Pre$udsed
nhalal
on,
solulion
I,
NAME
OF THE
MEDICINA!
PRODUCT
2.
QUALFATIVE
AND
OUANTITAIIVE
COMPOSITION
Aclive
su
bslan
€:
tunoteol
hydrcbrc
mid
o
1
aciu.ilon
@ila
ns 100
microgdn
lenotercl
hydrcbrom
de
Exc
pienl
uth
known
eff4r
Elhanol
99
%
(.lcohol)
(see
s.ci
on
4
4)
Fof lho
fu
Lst
of
excipienls,
see
Seclion
6
1
Summary
ol
Product Characteristics
(oeveloped
ror
!se
ln
(he
Rep!b
ic oi
amenia)
tl
CLINICAL PARTICULARS
svmoiomat
c
l@alneni
ol
acule aslhma
anacks
P6ohv axi.
ot ex€rc
s€-induced
brcnchlal
asthma
svmoiom.tio
l€ahenl
of bronchial
aslhna
of
a
leQic
or
non_.llerg
c
oliqin
a
rd/or
.ihe;
condirio^s
assoc
aied
slh
rcv€dib
e
obslruclion
ot tha
a
@vs
sirch
as
chrooic
obsltuclive
b@nchil
s
w
lh
or
w
lhod
pu
mo^ary
empnysema
iilong-rum
tea."nt
is
ne**ary
con@miranl
anl
nrlanmalory
lhe6pv
shourd be
4.2
Porology
and
m€thod
of.dmlnbtElion
Elldlsr
lh6
ooseo€Fts
ol
the.arrre
ald
$ventv
ollhedseaso
J{ettoll-etuiseo€sc'bed
r'"
rot".iq
a*"g*
r.
--.""t{
ror
adJlls
'1d(1
orc11on
r5e ase
or
3
veaa
Fo, lhe
aculo
lb.menr
ols-dde-
brolcr
alspasns
r_d
aiac's
o'btsrthless_e's
a
'
;;s;;;;;i
ioo
.';.r,,.
renorerc
lvdrcbtor
o'
{
a
aro
lsho-dbe
$ared
Gene
alrv,
n
an
a.Jre
aia6o'b
ea'1e554e$
a
\ng'e
r'lario-
's'f'cenrlorele"e
t;;6;
aeo'
I',hee
t
rc
rdr"be'i
o
oatr'l
oldh'e
5
a
rt.s
ale
.,
1
t8=
J.
a.41
hha lns
lh€
{iEl
aclualion.
a
second
aduar on
m.v
b€
inhaled
b€.lhlessn€$
€nnoi
be
allev aled
bv
a
se@nd
dose
r
mav
i i!
erercis€-induced
asthma
or
roreseeabre
ol
Berolec
should
be
l^ha
ed
if
pd$ibe
loLlow.
nepw
se
approach
baeed
on
rhe
*v€r
lv
should b€
monirored
bvmeans
olrcgurarmeorcal
more
acrusrions
In
such casos
pslienls
should be
adllsed lo
seek
med
€l
allendan@
'mmeo
ar.lv
see
5e.i
014
4)
svtrpaitTner
6
s
corqo'
ed
rcces$rY
$e
do*:
lradualiofsd'Bercle!3Jtirerperda/
lherae.rd00'6o
ec
1
ii.r^iJ"li""
oiei,.r."
+*ld
b"
selecrea
a6td
ne
to
the
lrcquenov
and
seveilv
or
$ebGatleeeressLsyrproaole.r€d)
-h'5s_oLdDea"oroaniadbv
o19
Pm
,.i
"n,.."r"^
r,ein""t.
oan
-
"l
"ir*r
i
r'